Gastrointestinal endoscopic injection hemostasis generally refers to endoscopic hemostasis, an endoscopic treatment modality that is primarily used to treat gastrointestinal bleeding.
Endoscopic hemostasis is a collective term for a method of treating gastrointestinal bleeding under endoscopy. Injection hemostasis refers to hemostasis by means of local injection of drugs such as anhydrous ethanol and sclerosing agents or local spraying of hemostatic agents into the bleeding site under endoscopy. Laser coagulation and electrocoagulation can also be considered to inhibit bleeding at the lesion site to achieve the purpose of hemostasis. Clinically, it can be used for gastrointestinal bleeding caused by various reasons.
It should be noted that endoscopic hemostasis is not recommended for patients with a combination of severe pharyngolaryngitis, acute upper respiratory tract infection, severe respiratory insufficiency, uncontrolled hypertension, heart failure and other diseases.
Patients who need endoscopic hemostasis should be under the guidance of a doctor.